painful diabetic peripheral neuropathy

Novaremed gets FDA nod for phase 2 trial of NRD135S.E1 for PDPN
Pharmaceutical Business Review
Wed, 06/24/20 - 10:21 am
Novaremed
FDA
clinical trials
NRD135S.E1
diabetes
painful diabetic peripheral neuropathy